UK markets closed

CinCor Pharma, Inc. (CINC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
29.16+0.12 (+0.41%)
At close: 04:00PM EST
28.60 -0.56 (-1.92%)
After hours: 07:44PM EST
Full screen
Trade prices are not sourced from all markets
Previous close29.04
Bid28.80 x 800
Ask29.95 x 800
Day's range28.94 - 29.16
52-week range10.53 - 43.15
Avg. volume600,316
Market cap1.276B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-6.40
Earnings date03 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est39.00
  • Motley Fool

    Why These Two Biotech Stocks Blasted Higher This Week

    Two somewhat under-the-radar biotech companies saw their share prices soar this week after agreeing to be acquired. CinCor Pharma (NASDAQ: CINC) is being bought out by deep-pocketed pharmaceutical company AstraZeneca, while Albireo Pharma (NASDAQ: ALBO) is set to be owned by France-based peer Ipsen. Both of these deals are very lucrative, to the point where CinCor's stock rocketed 146% over the course of the week, and Albireo shot 92% skyward, according to data compiled by S&P Global Market Intelligence.

  • Zacks

    Biotech Stock Roundup: REGN Down on Eylea Data, CINC Surges on AZN Offer & More

    Updates from Regeneron (REGN) and CinCor Pharma (CINC) are the key highlights from the biotech sector during the past week.

  • Zacks

    AstraZeneca (AZN) Set to Acquire CinCor Pharma for $1.3B

    AstraZeneca's (AZN) CinCor Pharma buyout is going to add blood pressure drug baxdrostat to its cardiorenal pipeline.